Integrated Drug Discovery and Development
Provider 
Founded 1947
Sells To Enterprise, Small Business
Pricing Model Recurring, Transactional
Ownership Public

Charles River integrated small-molecule drug discovery and development services.
Integrated Drug Discovery and Development is Charles River Laboratories' service combining biology, chemistry, and DMPK for pharmaceutical partners. It supports small-molecule programs from target validation through preclinical development.
The offering gives pharma and biotechnology clients a single partner for discovery and development, integrating multiple scientific disciplines under one program structure.
Beactica Therapeutics

Drug Discovery Partnerships
beactica.com
Alacrita

Preclinical Drug Development Consulting
alacrita.com
Adds products that compete with one of Integrated Drug Discovery and Development’s direct competitors but not with Integrated Drug Discovery and Development itself. They are shaded, and Linked Through names the direct competitor each one competes with.
Provider 
Founded 1947
Sells To Enterprise, Small Business
Pricing Model Recurring, Transactional
Ownership Public
Provider 
Founded 2006
Sells To Businesses
Pricing Model Pre-Revenue
Ownership Private
Provider 
Founded 2009
Sells To —
Pricing Model —
Ownership —
Linked Through Preclinical Drug Development Consulting
Provider 
Founded 2012
Sells To Enterprise
Pricing Model —
Ownership Private
Linked Through Preclinical Drug Development Consulting
Provider 
Founded 2012
Sells To —
Pricing Model —
Ownership —
Linked Through Drug Discovery Partnerships
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —
Linked Through Drug Discovery Partnerships
Provider 
Founded 1998
Sells To Enterprise
Pricing Model —
Ownership Public
Linked Through Preclinical Drug Development Consulting
Provider 
Founded 2011
Sells To Pharmaceutical Manufacturers
Pricing Model Service Fees
Ownership Private


Jubilant Biosys integrated small-molecule drug discovery services.


Pharmaron integrated drug discovery services with milestone-based models.


Drug discovery consulting service of Discovery Innovations, serving biotech and pharmaceutical partners from hit identification through preclinical candidate selection.


Drug discovery consulting services of transMedChem Consulting, spanning target validation through candidate identification.


Medicinal chemistry and drug discovery consulting service of ChemTract, led by owner James M. Balkovec.
Jubilant Biosys integrated small-molecule drug discovery services.

Pharmaron integrated drug discovery services with milestone-based models.

Drug discovery consulting service of Discovery Innovations, serving biotech and pharmaceutical partners from hit identification through preclinical candidate selection.

Drug discovery consulting services of transMedChem Consulting, spanning target validation through candidate identification.

Medicinal chemistry and drug discovery consulting service of ChemTract, led by owner James M. Balkovec.
